350 participants
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-03
- Start Date:
- 2022-01-19
- Completion:
- 2023-07-04
Conditions
- Crohn Disease
Interventions
- DRUG